Cholesterol-lowering and cancer in the prevention of cardiovascular disease

QJM: An International Journal of Medicine

Volumn 103, Issue 3, 2010, Pages 202-

  Oliver, M F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOFIBRATE; PLACEBO; TRIACYLGLYCEROL;

CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77950231761     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp186     Document Type: Letter

References (7)

1. Goldstein MR, Mascitelli L, Pezzatta E. Primary prevention of cardiovascular disease with statins: cautionary notes. Q J Med 2009; 102:817-24.
2. Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Cobbe SM, et al.; on behalf of the PROSPER study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised control trial. Lancet 2002; 360:1613-30.
3. Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, et al.; for the LIPID Investigators. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Ann Intern Med 2001; 134:931-40.
4. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al.; for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001-9.
5. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe S; for the West of Scotland Coronary Prevention Study Group. N Engl J Med 2007; 357:1477-86.
6. Report from the Committee of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Brit Heart J 1978; 40:1069-118.
7. Report from the Committee of Principal Investigators. WHO Cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 1984; ii:600-4.